People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...
For the first time since 2017, Canadian doctors have released updated clinical guidelines for antiretroviral medications used ...
Smithsonian Magazine on MSN
A New Trial Put Immune System-Boosting Therapies to the Test to Fight HIV, Raising Hopes for Keeping the Virus at Bay
In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
UCSF researchers have made strides toward an HIV cure, showing experimental immunotherapy can help control the virus without ...
Seven of 10 volunteers kept HIV at bay for months after stopping meds, a rare result scientists call a major step toward a ...
HIV treatment has delivered life-altering advantages. Antiretroviral therapy has led to a reduced mortality and improved life ...
Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...
Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results